We are proud of...

Dr. Mutasem Rawas-Qalaji in the NSU Research Spotlight: NSU Researcher Develops a New Non-Invasive Dosage Form for the Treatment of Anaphylaxis.
Dr. Rawas-Qalaji
Studies have shown that the United States has one of the highest incidences of fatal anaphylaxis in the world. For anaphylaxis treatment in community settings, epinephrine intramuscular injection using an auto-injector, e.g. EpiPen®, in the thigh is universally recommended. Despite this, many people at risk of anaphylaxis in community settings do not carry their prescribed auto-injectors consistently and hesitate to use them when anaphylaxis occurs. Mutasem Rawas-Qalaji, B. Pharm., Ph.D., associate professor of pharmaceutics at NSU’s College of Pharmacy, along with his research team, developed a novel sublingual tablet that disintegrates and releases the medicinal ingredient, epinephrine, under the patient’s tongue within less than 30 seconds. These rapidly disintegrating sublingual epinephrine tablets are taste-masked to enhance tablet’s palatability and patients’ acceptance. Recently, the NSU research team was able to significantly enhance the amount of drug that gets absorbed from the sublingual cavity into the blood, i.e. the relative bioavailability, through reducing the particles size of epinephrine using micro and nanotechnology.
Read more on NSU News.

Dr. Ana M. Castejón and Dr. Richard C. Deth on Local 10 News - New research helps children with Autism.
Ana Castejon, Ph.D.

Congratulations, Dr. Castejón and Dr. Deth!

Click on the image or here to view the video.
College of Pharmacy Alumni David Pino, Pharm.D., ('10) elected InterAmerican Pharmacists Association President. 
Dr. D. Pino
Dr. David Pino has been involved in the political aspects of pharmacy since starting his second year of the PharmD program at Nova Southeastern University. He ran for NSU’s American Pharmacists Association student organization (APhA-ASP) and was elected Communication and Technology Coordinator for 3 years until graduating in 2010. During those years of service, he represented NSU at the APhA Convention held in Washington D.C. and helped organize community outreach events to further educate the public on how pharmacists can make a difference in health-care. Upon graduating in 2010, Dr. Pino began working at Walgreens where he was able to become pharmacy manager of a Diabetes Center of Excellence for his community. Currently, Dr. Pino is also a member of InterAmerican Pharmacists Association (IPA) where he has helped to coordinate multiple continuing education seminars to enhance pharmacists' knowledge and serve the pharmacist community before becoming president of IPA in 2014. He also attended the Florida Pharmacists Association 2014 convention as a delegate for IPA to help shape the future of pharmacy and was nominated and elected to be the Director of the FPA House of Delegates.

Ana M. Castejón, Ph.D., Associate Professsor, College of Pharmacy, interviewed on CNN en Español.
Ana Castejon, Ph.D.

On April 8, 2015 Ana M. Castejón, PhD, Associate Professsor, College of Pharmacy, was interviewed on CNN en Español, “Vive la Salud con Dra. Azaret” focusing on her research related to nutrition and autism.  Dr. Castejon is currently the Principal Investigator (PI) of an ongoing multidisciplinary research study about the role of glutathione in autism. This multidisciplinary study involves different NSU academic centers and is the first Investigator-Initiated clinical trial at NSU. As the PI of this project, Dr. Castejon, is in charge of designing and implementing a study investigating a nutritional supplement and its role in behavioral changes in children with autism. In addition, she was responsible for creating a protocol and method to quantify glutathione in children with autism spectrum disorders.  Congratulations, Dr. Castejón!

Dr. Hossein Omidian and Dr. David Mastropietro featured on WSVN (FOX 7) story that includes tamper-proof medication research being conducted by NSU’s College of Pharmacy.

Click here for WSVN webpage covering the story.
Dr. Marylee Worley quoted in a CBS 4 story on the powerful antibiotic Levaquin.

If you have difficulties seeing the video - click here.
Dr. Joshua Caballero - one of the authors of position paper in the College of Psychiatric & Neurologic Pharmacists (CPNP).
Dr. Caballero

The College of Psychiatric & Neurologic Pharmacists (CPNP) has developed an official position paper to help increase patient access to comprehensive medication management and to support efforts to obtain payment for the service. The CPNP Position Paper – Improving Medication-Related Outcomes for Patients with Psychiatric or Neurologic Disorders: Value of Psychiatric Pharmacists as Part of the Healthcare Team – reviews the need for psychiatric pharmacists, the unique training and experience of the psychiatric pharmacist, outcomes from studies specifically examining interventions for patients with psychiatric and neurological disorders, and comprehensive medication management. The full version of this paper can be found in the January 2015 issue of the Mental Health Clinician and can be downloaded in PDF version.

Dr. Jean Latimer - lead investigator in the study that finds DNA repair is high in heart, nonexistent in brain. Results could help explain causes of dementia and memory loss.
Dr. Latimer

The research team consisted of Latimer; Stephen Grant, Ph.D., associate professor of public health, NSU’s College of Osteopathic Medicine; NSU College of Pharmacy students Vongai Majekwana, Pharm.D. candidate; and Yashira Pabón-Padín, Pharm.D. candidate; and Manasi Pimpley, Ph.D. candidate. 

Their findings are published in the peer-reviewed journal, Photochemistry and Photobiology in an article titled “Regulation and dysregulation of mammalian nucleotide excision repair: a pathway to non-germline breast carcinogenesis.” Read the full article.

Dr. Anastasios Lymperopoulos in the "NSU Research Spotlight: NSU Researcher Discovers Certain ARB Drugs are more Effective than others at Treating Heart Failure"
Dr. Lymperopoulos

Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure. But it turns out not all ARBs are created equally, according to one Nova Southeastern University (NSU) researcher’s findings. Anastasios Lymperopoulos, Ph.D., F.A.H.A., assistant professor of pharmacology at NSU’s College of Pharmacy, along with his research team, conducted a study on biological models over a seven-day period that found Valsartan (Diovan) and Candesartan (Atacand) were more effective than Irbesartan (Aprovel, Karvea and Avapro) at preventing the increased production of the hormone aldosterone, which, if untreated, can lead to heart failure. “This can help cardiologists and other clinicians tremendously when they are deciding which ARB drug to choose for the treatment of heart failure patients,” Lymperopoulos said. Read more...

NSU College of Pharmacy Student Chapter of SCCP featured in ACCP's "STUNEWS"
STUNEWSRead more
NSU Colleges of Pharmacy and Osteopathic Medicine Host Interdisciplinary Community Health Check
Interdisciplinary NSU College of Osteopathic Medicine (COM) and NSU College of Pharmacy (COP) representatives pose together at Walgreens. Left to right: Claudia Vallin (COM student), Diana Hernández (COP student), Giselle Farinas (COP student), Jessica Greenwood (COP student), Garrett Van Ostran (COM student), Leany Alexis Capote (COP student), and José Valdes, Pharm.D. (COP faculty member and alumnus).

On Nov. 1, 2014, the Student College of Clinical Pharmacy from NSU’s College of Pharmacy (COP), and the NeuroPsych Club from NSU’s College of Osteopathic Medicine partnered with Walgreens on Coral Way in Miami to offer free blood pressure and blood glucose screenings to members of the community. Walgreens provided the necessary equipment and supplies. COP assistant professors José Valdes, Pharm.D., (Class of 2012) and Taylor Butler, Pharm.D., generously volunteered their time to provide medication counseling and supervision. Read more...

Dr. Ana M. Castejon in "NSU Research Spotlight: Autism Spectrum Disorder"
Dr. Castejon

NSU and the dietary supplement company Immunotec are conducting a research study to determine the effects of a supplement to improve behaviors in children with autism spectrum disorder. The study will investigate the effects of a cysteine-rich whey protein isolate in children diagnosed with autism. The primary function of this research is to establish whether taking a 90-day diet of cysteine-rich whey proteins (which comes in a powder form), will have a positive effect on autistic behaviors. Improvements in affected behaviors may result in an enhanced quality of life for both children and their families. During the clinical study, there will be an analysis of the children’s exhibited behaviors. Autism is a neurodevelopmental disorder currently affecting as many as 1 in 68 children in the United States. Read more...

Dr. Appu Rathinavelu in "NSU Research Spotlight: Cancer Research"
Dr. Rathinavelu

During his graduate studies nearly 30 years ago, Appu Rathinavelu, now a Ph.D., visited a cancer research institute in India where he witnessed patients facing serious side effects from chemotherapy drugs. This experience inspired him to pursue a field that allowed him to develop new therapeutic approaches that are less toxic, more affordable, and have better results. When he joined NSU’s College of Pharmacy in 1992 and began conducting research that will make a significant difference in countless lives, he moved closer to making his dream a reality. He and his team at NSU’s Rumbaugh-Goodwin Institute for Cancer Research are focused on developing new methods for early detection of cancer and discovering new drugs that provide less toxic treatments for cancer. Read more...

Dr. Anastasios (Tassos) Lymperopoulos in "NSU Research Spotlight: Pharmaceutical Sciences"
Dr. Lymperopoulos

Anastasios (Tassos) Lymperopoulos, Ph.D., seeks to discover new treatments for cardiovascular disease, which kills more people than cancer. Right now, his “patients” are mice and rats. But Lymperopoulos has dedicated his professional life to the premise that cutting-edge gene therapy techniques will produce important benefits for humans. “I have always liked science, then I got hooked on the science behind drugs. Then, in my mentor’s Philadelphia biomedical research lab, I started working on the heart,” Lymperopoulos explains. His mother died from a stroke shortly before he came to the United States from his native Greece, and this stimulated his interest. In Philadelphia, he tested the practicality of an approach to delivering proteins to the hearts of animals through certain cell surface receptors. “It was a make-or-break moment where I would either hit a home run or reach a sudden dead end. Fortunately, I validated the concept, and this set me up for a lifetime career,” he says. Read more...

Dr. Robert Speth in "NSU Research Spotlight: Pharmaceutical Sciences"
Dr. Robert Speth

While taking his first college psychology course, Bob Speth, now a Ph.D., decided that he wanted to figure out how the brain works. “At that time, I had no idea that the brain had 100 billion cells, all making connections with each other. I’m still working at my goal, though I have scaled back my expectations,” he says. Now an NSU professor of pharmaceutical sciences, Speth has characterized a brain protein that forms a blood pressure-lowering hormone, which could eventually reduce the incidence of heart disease. “I have six people in the laboratory going full bore on what I hope will become a valuable research tool,” he says. Read more...

Dr. Jean Latimer in "NSU Research Spotlight: Cancer Research"
Dr. Jean Latimer

Losing a friend to leukemia in high school was a life changing event for Jean Latimer, Ph.D. Always interested in science, Latimer initially considered becoming a doctor. Then she began thinking about the unchartered territory in which doctors didn’t have all the answers. Her epiphany came at age 16 when she realized that, if she wanted to develop cures and treatments, she should become a scientist instead. Now a breast cancer and leukemia researcher in the College of Pharmacy, Latimer says: “Most doctors are busy treating their patients. Sometimes, all they can do is say, ‘I’m sorry.’ We are the ones who write the textbooks for medical school.” Latimer leads a team that investigates human breast tissue for DNA damage that originates from environmental causes. She has developed a unique method of growing breast cancer cells from tumors at early stages of the disease, enabling further studies into the causes of tumors and indicating when and what kind of chemotherapy would provide the best response. Read more...

NSU College of Pharmacy featured on Channel 10 Local News
Dr. Goar Alvarez

NSU College of Pharmacy was featured on the local news channel segment HEALTHCAST about pharmacists' roles expanding as demand for primary care physicians goes up. Featured in the broadcast are: faculty and NSU Clinic Pharmacy director Goar Alvarez, PharmD., faculty Andrea Fass, PharmD., P2 student Levi Morris and other students, as well as patients and pharmacists in our clinic pharmacy. (View the video on the Chanel 10 website or by clicking on the image above.)

COP Research Fellow Wins International Microsoft Health App Challenge
Zaher Hajar, Pharm.D.
Zaher Hajar, Pharm.D.
Research Fellow,
College of Pharmacy

Research Fellow Zaher Hajar, PharmD. Recently, Dr. Hajar, who is at the College of Pharmacy (COP) Center for Consumer Health Informatics Research, assembled a team of clinicians and coders in response to an international app challenge by Microsoft and Health 2.0. The “Re-imagining Consumer Health With Windows 8 And Healthvault Challenge” called upon innovators to design a ”next generation health management app”. Dr. Hajar and the team, comprised of NSU COP faculty Kevin A. Clauson, PharmD and evangelists from Techmind, created an app named Health eConnect and submitted their entry. Following deliberation by a panel of judges from Microsoft, it was recently announced on Health 2.0 News that NSU’s Health eConnect app was crowned the winner of the app challenge. As the first place winner, the team is awarded $10,000, a Microsoft Surface Pro, and inclusion as one of Microsoft preferred Window 8 partners. Submission of the Health eConnect app to the Windows Store under terms of the challenge also grants a waiver of the standard Go-Live fee ($20,000) in addition to other benefits tied to HealthVault fees.

More >>

The shark research led by Dr. Nathan Unger (featured by CNN)

COP Faculty Member Dr. Jose A. Rey Featured on Pharmacy Today
Jose A. Rey, MS, PharmD, BCCP

If the anthrax attacks of 2001 had been as bad as many feared, the country would have needed not only a public response to the lethal bacteria, but also to the potentially dangerous adverse effects of the antibiotic ciprofloxacin.
"If we were all on [ciprofloxacin], maybe one in 100 would have pretty bad anxiety - on top of the anxiety that an anthrax attack would cause," explained Jose A. Rey, MS, PharmD, BCCP. "People have had seizures on this antibiotic, and it can make you anxious, agitated, and aggressive." More >>

"Pediatric Pharmacotherapy" book authored by Dr. Sandra Benavides.
Book cover

Sandra Benavides, Pharm.D., and 
Milap C. Nahata, Pharm.D, FCCP, Lead Editors

Pediatric Pharmacotherapy focuses on the unique therapeutic needs of neonates, infants, children, and adolescents. Patients in these age groups offer challenges distinct from those of adult patients. Drugs behave differently in this population—medications may not be absorbed, distributed, metabolized, or eliminated in the same manner as in adults, causing increased or decreased efficacy or safety. For a long time, pharmacotherapy educators have been without a source for concise pediatric-specific pharmacotherapy information. More >>

"Get the Residency" book authored by Dr. Joshua Caballero, Dr. K. Clauson, and Dr.S. Benavides
Book cover - Caballero

Competition for pharmacy residency positions has intensified greatly in recent years, with a national average of only 60% of candidates able to secure one. Based on the results of an innovative course pioneered at Nova Southeastern University (NSU) that helped over 80% of enrolled students obtain a residency position, the American Society of Health-System Pharmacists (ASHP) commissioned the book, Get the Residency. This is particularly notable as ASHP is the accreditation body for pharmacy residencies nationally, thus adding considerable cache to this NSU faculty-edited (and predominantly authored) reference. Publication of Get the Residency is the result of both the student-centered approach demonstrated by NSU faculty as well as their nationally recognized expertise.

PHARMACEUTICAL RESEARCH in our College of Pharmacy
View below a short presentation of Dr. Omidian's Research Group

More about research in COP...

Garden of Tranquility

More about Medicinal Garden... 

Accreditation Meessage
Click here for Dean's Message.

Make NSU your destination for pharmacy education!

COP ad
Alumni Luncheons

College of Pharmacy Celebrates its 25th Anniversary

25 Anniversary
Since its inception in 1987, the College of Pharmacy has been a leader in pharmacy education and research throughout the United States.


Past Events

Stay connected:
facebook   YouTube   twitter   linkedin   Google Plus